Centre hospitalier de l'Université de Montréal

• Impact of Intravenous Dexamethasone on the Duration of Motor and Sensory Block Following Spinal Anesthesia With Chloroprocaine

  Not yet recruiting, 60 people, 23 Sept 2026

• NCT06923540

  Phase 4, Not yet recruiting, 140 people, 11 Apr 2025

• NCT06099379

  Phase 1/2, Recruiting, 100 people, 25 Oct 2023

• NCT05986318

  Collaborator, Phase 2, Recruiting, 98 people, 14 Aug 2023

• NCT05785065

  Phase 2, Recruiting, 35 people, 27 Mar 2023

• NCT05407285

  Phase 1/2, Completed, 70 people, 7 Jun 2022

• NCT05358639

  Collaborator, Phase 1, Active, not recruiting, 36 people, 3 May 2022

• NCT05320367

  Phase 1/2, Not yet recruiting, 80 people, 11 Apr 2022

• NCT04118920

  Phase 1, Status unknown, 18 people, 8 Oct 2019

• NCT03767933

  Collaborator, Phase 2, Completed, 710 people, 7 Dec 2018

• NCT03764540

  Phase 2, Terminated, 57 people, 5 Dec 2018

• NCT03115047

  Phase 3, Completed, 80 people, 14 Apr 2017

• NCT02559167

  Phase 2, Completed, 79 people, 24 Sept 2015

• NCT02291666

  Phase 4, Completed, 73 people, 14 Nov 2014

• NCT01771198

  Phase 2, Terminated, 7 people, 18 Jan 2013

• NCT01399645

  Phase 2, Completed, 35 people, 22 Jul 2011

• NCT01146483

  Phase 1, Completed, 16 people, 17 Jun 2010

• NCT00157690

  Collaborator, Phase 4, Completed, 56 people, 12 Sept 2005

Sources: clinicaltrials.gov